Amylyx Pharmaceuticals IncNASDAQ:AMLX
- LAST PRICE5.7050
- TODAY'S CHANGE (%)0.0650 (1.1525%)
- Bid / Lots5.7000/ 1
- Ask / Lots5.7300/ 1
- Open / Previous Close5.5800 / 5.6400
- Day Range
- 52 Week Range
- Volume841,141
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 10500 | 5.595 |
| 09:33 ET | 2423 | 5.66 |
| 09:35 ET | 7969 | 5.59 |
| 09:37 ET | 9983 | 5.53 |
| 09:39 ET | 8400 | 5.54 |
| 09:42 ET | 26178 | 5.52 |
| 09:44 ET | 14928 | 5.55 |
| 09:46 ET | 10416 | 5.62 |
| 09:48 ET | 1500 | 5.6095 |
| 09:50 ET | 4823 | 5.59 |
| 09:51 ET | 3365 | 5.59 |
| 09:53 ET | 565 | 5.5815 |
| 09:55 ET | 4287 | 5.59 |
| 09:57 ET | 530 | 5.618 |
| 10:00 ET | 1681 | 5.65 |
| 10:02 ET | 5234 | 5.71 |
| 10:04 ET | 1499 | 5.73 |
| 10:06 ET | 4451 | 5.68 |
| 10:08 ET | 2402 | 5.6712 |
| 10:09 ET | 733 | 5.69 |
| 10:11 ET | 2370 | 5.705 |
| 10:13 ET | 8930 | 5.72 |
| 10:15 ET | 7727 | 5.685 |
| 10:18 ET | 1141 | 5.675 |
| 10:20 ET | 1840 | 5.684 |
| 10:22 ET | 18089 | 5.72 |
| 10:24 ET | 6502 | 5.75 |
| 10:26 ET | 6676 | 5.73 |
| 10:27 ET | 2320 | 5.745 |
| 10:29 ET | 2000 | 5.745 |
| 10:31 ET | 13675 | 5.755 |
| 10:33 ET | 1390 | 5.755 |
| 10:36 ET | 5249 | 5.74 |
| 10:38 ET | 3848 | 5.75 |
| 10:40 ET | 4750 | 5.745 |
| 10:42 ET | 3498 | 5.73 |
| 10:44 ET | 500 | 5.735 |
| 10:45 ET | 8194 | 5.725 |
| 10:47 ET | 3064 | 5.715 |
| 10:49 ET | 1255 | 5.735 |
| 10:51 ET | 1300 | 5.735 |
| 10:54 ET | 2388 | 5.755 |
| 10:56 ET | 2017 | 5.745 |
| 10:58 ET | 993 | 5.74 |
| 11:00 ET | 1714 | 5.735 |
| 11:02 ET | 5327 | 5.71 |
| 11:03 ET | 1400 | 5.71 |
| 11:05 ET | 2672 | 5.71 |
| 11:07 ET | 300 | 5.695 |
| 11:09 ET | 2000 | 5.705 |
| 11:12 ET | 4847 | 5.705 |
| 11:14 ET | 800 | 5.705 |
| 11:16 ET | 23521 | 5.695 |
| 11:18 ET | 7220 | 5.695 |
| 11:20 ET | 2983 | 5.6841 |
| 11:21 ET | 1446 | 5.675 |
| 11:23 ET | 19102 | 5.705 |
| 11:25 ET | 1900 | 5.69 |
| 11:27 ET | 100 | 5.69 |
| 11:30 ET | 1400 | 5.69 |
| 11:34 ET | 2250 | 5.69 |
| 11:36 ET | 2200 | 5.685 |
| 11:38 ET | 1584 | 5.68 |
| 11:39 ET | 300 | 5.675 |
| 11:41 ET | 3500 | 5.6693 |
| 11:43 ET | 1635 | 5.68 |
| 11:45 ET | 3253 | 5.6599 |
| 11:48 ET | 7500 | 5.642 |
| 11:50 ET | 3036 | 5.645 |
| 11:52 ET | 416 | 5.635 |
| 11:54 ET | 2239 | 5.62 |
| 11:56 ET | 700 | 5.625 |
| 11:57 ET | 500 | 5.625 |
| 11:59 ET | 1400 | 5.63 |
| 12:01 ET | 1800 | 5.605 |
| 12:03 ET | 1500 | 5.61 |
| 12:06 ET | 2153 | 5.5901 |
| 12:08 ET | 18291 | 5.65 |
| 12:10 ET | 1970 | 5.665 |
| 12:12 ET | 4038 | 5.655 |
| 12:14 ET | 1900 | 5.655 |
| 12:15 ET | 500 | 5.655 |
| 12:17 ET | 200 | 5.655 |
| 12:19 ET | 400 | 5.655 |
| 12:21 ET | 800 | 5.66 |
| 12:24 ET | 780 | 5.6611 |
| 12:26 ET | 1200 | 5.66 |
| 12:28 ET | 300 | 5.665 |
| 12:30 ET | 3939 | 5.665 |
| 12:32 ET | 800 | 5.675 |
| 12:33 ET | 830 | 5.675 |
| 12:35 ET | 100 | 5.675 |
| 12:37 ET | 850 | 5.675 |
| 12:39 ET | 1800 | 5.695 |
| 12:42 ET | 2216 | 5.705 |
| 12:44 ET | 2390 | 5.705 |
| 12:46 ET | 2073 | 5.715 |
| 12:48 ET | 860 | 5.715 |
| 12:50 ET | 2380 | 5.711 |
| 12:51 ET | 4499 | 5.71 |
| 12:53 ET | 1942 | 5.7012 |
| 12:55 ET | 1069 | 5.705 |
| 12:57 ET | 4880 | 5.705 |
| 01:00 ET | 726 | 5.71 |
| 01:02 ET | 500 | 5.705 |
| 01:04 ET | 5900 | 5.675 |
| 01:06 ET | 1000 | 5.655 |
| 01:08 ET | 2026 | 5.655 |
| 01:09 ET | 700 | 5.65 |
| 01:11 ET | 2050 | 5.68 |
| 01:13 ET | 2200 | 5.695 |
| 01:15 ET | 1021 | 5.695 |
| 01:18 ET | 501 | 5.69 |
| 01:22 ET | 609 | 5.695 |
| 01:24 ET | 323 | 5.695 |
| 01:26 ET | 3200 | 5.725 |
| 01:27 ET | 526 | 5.745 |
| 01:29 ET | 2135 | 5.755 |
| 01:31 ET | 5618 | 5.765 |
| 01:33 ET | 1450 | 5.775 |
| 01:36 ET | 8689 | 5.7949 |
| 01:38 ET | 5658 | 5.775 |
| 01:40 ET | 3733 | 5.755 |
| 01:42 ET | 1599 | 5.7538 |
| 01:44 ET | 947 | 5.7599 |
| 01:45 ET | 1237 | 5.765 |
| 01:47 ET | 1667 | 5.765 |
| 01:49 ET | 2501 | 5.765 |
| 01:54 ET | 652 | 5.765 |
| 01:56 ET | 1668 | 5.76 |
| 01:58 ET | 3100 | 5.765 |
| 02:00 ET | 1487 | 5.7501 |
| 02:02 ET | 2000 | 5.77 |
| 02:03 ET | 200 | 5.76 |
| 02:05 ET | 1418 | 5.755 |
| 02:07 ET | 2900 | 5.745 |
| 02:09 ET | 6984 | 5.73 |
| 02:12 ET | 1569 | 5.72 |
| 02:14 ET | 1800 | 5.725 |
| 02:16 ET | 195 | 5.725 |
| 02:18 ET | 520 | 5.73 |
| 02:20 ET | 1688 | 5.7328 |
| 02:21 ET | 300 | 5.735 |
| 02:23 ET | 594 | 5.74 |
| 02:25 ET | 688 | 5.7415 |
| 02:27 ET | 1000 | 5.745 |
| 02:30 ET | 3377 | 5.7499 |
| 02:32 ET | 1024 | 5.735 |
| 02:34 ET | 1935 | 5.755 |
| 02:36 ET | 100 | 5.755 |
| 02:38 ET | 1571 | 5.765 |
| 02:39 ET | 4247 | 5.735 |
| 02:41 ET | 800 | 5.7328 |
| 02:43 ET | 700 | 5.72 |
| 02:45 ET | 100 | 5.725 |
| 02:48 ET | 100 | 5.725 |
| 02:50 ET | 2189 | 5.725 |
| 02:52 ET | 500 | 5.725 |
| 02:56 ET | 324 | 5.7288 |
| 02:57 ET | 1000 | 5.735 |
| 02:59 ET | 651 | 5.735 |
| 03:01 ET | 1233 | 5.75 |
| 03:03 ET | 9395 | 5.745 |
| 03:06 ET | 2596 | 5.745 |
| 03:08 ET | 1304 | 5.735 |
| 03:10 ET | 1429 | 5.745 |
| 03:12 ET | 9700 | 5.725 |
| 03:14 ET | 100 | 5.725 |
| 03:15 ET | 2333 | 5.7201 |
| 03:17 ET | 1161 | 5.735 |
| 03:19 ET | 2527 | 5.724 |
| 03:21 ET | 100 | 5.725 |
| 03:24 ET | 1725 | 5.715 |
| 03:26 ET | 1553 | 5.725 |
| 03:28 ET | 2302 | 5.725 |
| 03:30 ET | 400 | 5.725 |
| 03:32 ET | 2803 | 5.725 |
| 03:33 ET | 1398 | 5.725 |
| 03:35 ET | 1452 | 5.725 |
| 03:37 ET | 1650 | 5.715 |
| 03:39 ET | 1944 | 5.705 |
| 03:42 ET | 2800 | 5.715 |
| 03:44 ET | 2840 | 5.725 |
| 03:46 ET | 2220 | 5.7247 |
| 03:48 ET | 3020 | 5.715 |
| 03:50 ET | 4408 | 5.725 |
| 03:51 ET | 2401 | 5.725 |
| 03:53 ET | 8281 | 5.7 |
| 03:55 ET | 5860 | 5.694 |
| 03:57 ET | 6869 | 5.695 |
| 04:00 ET | 78869 | 5.705 |
Yesterday
Press Release: Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024, from 16 hours ago by Dow Jones
16 hours ago by Dow JonesAmylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024, from 16 hours ago by Dow Jones
16 hours ago by Dow Jones
Oct 18, 2024
DJ Amylyx Pharmaceuticals Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 6:45AM ET on Friday Oct 18, 2024 by Dow Jones
6:45AM ET on Friday Oct 18, 2024 by Dow Jones
Oct 17, 2024
Oct 15, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 388.1M | -2.3x | --- |
Organogenesis Holdings Inc | 396.4M | -23.9x | --- |
Amarin Corporation PLC | 248.7M | -6.3x | --- |
Ironwood Pharmaceuticals Inc | 669.3M | 97.0x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Ginkgo Bioworks Holdings Inc | 401.2M | -0.4x | --- |
Company Information
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Contact Information
- Headquarters
- 43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
- Phone
- 617-682-0917
- Fax
- 302-636-5454
Executives
- Chair of the Board of Directors
- George Milne
- Co-Chief Executive Officer, Director
- Joshua Cohen
- Co-Chief Executive Officer, Director
- Justin Klee
- Chief Financial Officer
- James Frates
- Chief Legal Officer and General Counsel
- Gina Mazzariello
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $388.1M |
|---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
